<p>A : Proportions of patients with type 1 diabetes (white columns), type 2 diabetes (hatched columns) and from the total study population (black columns) reporting light (numerical rating score from 1 to 3 out of 10), moderate (numerical rating score from 4 to 6 out of 10) or severe (numerical rating score from 7 to 10) average pain intensity over the last week. B : Proportions of patients with type 1 diabetes (white columns), type 2 diabetes (hatched columns) and from the the total study population (black columns), reporting chronic pain for 3 to 6 months, 7 to 12 months, 13 to 36 months and more than 36 months.</p
Objective: The aim of the study was to assess pain threshold and tolerance in diabetics with/without...
Aims To compare reported level of bodily pain, overall and health‐related quality of life (QoL), dep...
OBJECTIVE—To determine the prevalence of painful diabetic peripheral neuropathy (PDPN) in a populati...
<p>Proportions of patients with type 1 diabetes (white columns), type 2 diabetes (hatched columns) a...
<p>A : Comparisons of the physical and mental scores of the SF-12 questionnaire between patients wit...
Peripheral neuropathy affects about 30% of people with diabetes mellitus (DM). Between 16% and 26% o...
OBJECTIVE: To investigate the prevalence, location and severity of pain, as well as its association ...
Objective: Our aim was to estimate the prevalence of distal chronic pain with neuropathic characteri...
Objective: The principal aim of this study was to identify factors influencing the severity of perip...
• Diabetes mellitus affects approximately 23.6 million adults in the United States (US) and an estim...
Background: Peripheral neuropathies are a common complication in patients with diabetes. Changes in...
The aim of our study was to determine whether diabetic ST segment elevation myocardial infarction (S...
OBJECTIVEdTo assess, in the general diabetic population, 1) the prevalence of painful neu-ropathic s...
The aim of our study was to determine whether diabetic ST segment elevation myocardial infarction (S...
Background: Peripheral neuropathies are a common complication in patients with diabetes. Changes in ...
Objective: The aim of the study was to assess pain threshold and tolerance in diabetics with/without...
Aims To compare reported level of bodily pain, overall and health‐related quality of life (QoL), dep...
OBJECTIVE—To determine the prevalence of painful diabetic peripheral neuropathy (PDPN) in a populati...
<p>Proportions of patients with type 1 diabetes (white columns), type 2 diabetes (hatched columns) a...
<p>A : Comparisons of the physical and mental scores of the SF-12 questionnaire between patients wit...
Peripheral neuropathy affects about 30% of people with diabetes mellitus (DM). Between 16% and 26% o...
OBJECTIVE: To investigate the prevalence, location and severity of pain, as well as its association ...
Objective: Our aim was to estimate the prevalence of distal chronic pain with neuropathic characteri...
Objective: The principal aim of this study was to identify factors influencing the severity of perip...
• Diabetes mellitus affects approximately 23.6 million adults in the United States (US) and an estim...
Background: Peripheral neuropathies are a common complication in patients with diabetes. Changes in...
The aim of our study was to determine whether diabetic ST segment elevation myocardial infarction (S...
OBJECTIVEdTo assess, in the general diabetic population, 1) the prevalence of painful neu-ropathic s...
The aim of our study was to determine whether diabetic ST segment elevation myocardial infarction (S...
Background: Peripheral neuropathies are a common complication in patients with diabetes. Changes in ...
Objective: The aim of the study was to assess pain threshold and tolerance in diabetics with/without...
Aims To compare reported level of bodily pain, overall and health‐related quality of life (QoL), dep...
OBJECTIVE—To determine the prevalence of painful diabetic peripheral neuropathy (PDPN) in a populati...